id sg-nus-scholar.10635-181424
record_format dspace
spelling sg-nus-scholar.10635-1814242024-04-12T05:48:31Z Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study Augustin, A.J Kuppermann, B.D Lanzetta, P OPHTHALMOLOGY DUKE-NUS MEDICAL SCHOOL angiogenesis inhibitor dexamethasone drug implant glucocorticoid immunosuppressive agent triamcinolone acetonide vasculotropin A VEGFA protein, human aged antagonists and inhibitors clinical trial controlled study diabetic retinopathy drug effects drug implant female human intravitreal drug administration macular edema male middle aged multicenter study optical coherence tomography pathophysiology phase 3 clinical trial randomized controlled trial retreatment visual acuity Aged Angiogenesis Inhibitors Dexamethasone Diabetic Retinopathy Drug Implants Female Glucocorticoids Humans Immunosuppressive Agents Intravitreal Injections Macular Edema Male Middle Aged Retreatment Tomography, Optical Coherence Triamcinolone Acetonide Vascular Endothelial Growth Factor A Visual Acuity 10.1186/s12886-015-0148-2 BMC Ophthalmology 15 1 150 2020-10-27T10:52:56Z 2020-10-27T10:52:56Z 2015 Article Augustin, A.J, Kuppermann, B.D, Lanzetta, P (2015). Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study. BMC Ophthalmology 15 (1) : 150. ScholarBank@NUS Repository. https://doi.org/10.1186/s12886-015-0148-2 14712415 https://scholarbank.nus.edu.sg/handle/10635/181424 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic angiogenesis inhibitor
dexamethasone
drug implant
glucocorticoid
immunosuppressive agent
triamcinolone acetonide
vasculotropin A
VEGFA protein, human
aged
antagonists and inhibitors
clinical trial
controlled study
diabetic retinopathy
drug effects
drug implant
female
human
intravitreal drug administration
macular edema
male
middle aged
multicenter study
optical coherence tomography
pathophysiology
phase 3 clinical trial
randomized controlled trial
retreatment
visual acuity
Aged
Angiogenesis Inhibitors
Dexamethasone
Diabetic Retinopathy
Drug Implants
Female
Glucocorticoids
Humans
Immunosuppressive Agents
Intravitreal Injections
Macular Edema
Male
Middle Aged
Retreatment
Tomography, Optical Coherence
Triamcinolone Acetonide
Vascular Endothelial Growth Factor A
Visual Acuity
spellingShingle angiogenesis inhibitor
dexamethasone
drug implant
glucocorticoid
immunosuppressive agent
triamcinolone acetonide
vasculotropin A
VEGFA protein, human
aged
antagonists and inhibitors
clinical trial
controlled study
diabetic retinopathy
drug effects
drug implant
female
human
intravitreal drug administration
macular edema
male
middle aged
multicenter study
optical coherence tomography
pathophysiology
phase 3 clinical trial
randomized controlled trial
retreatment
visual acuity
Aged
Angiogenesis Inhibitors
Dexamethasone
Diabetic Retinopathy
Drug Implants
Female
Glucocorticoids
Humans
Immunosuppressive Agents
Intravitreal Injections
Macular Edema
Male
Middle Aged
Retreatment
Tomography, Optical Coherence
Triamcinolone Acetonide
Vascular Endothelial Growth Factor A
Visual Acuity
Augustin, A.J
Kuppermann, B.D
Lanzetta, P
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
description 10.1186/s12886-015-0148-2
author2 OPHTHALMOLOGY
author_facet OPHTHALMOLOGY
Augustin, A.J
Kuppermann, B.D
Lanzetta, P
format Article
author Augustin, A.J
Kuppermann, B.D
Lanzetta, P
author_sort Augustin, A.J
title Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
title_short Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
title_full Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
title_fullStr Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
title_full_unstemmed Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
title_sort dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the mead study
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/181424
_version_ 1800914636576391168